Company Information & Drug Savings for Samsung Bioepis Co., Ltd. Medications
Samsung Bioepis is a South Korean biopharmaceutical company developing biosimilar products. The company manufactures and markets high-quality biosimilars to expensive biologic drugs including adalimumab, infliximab, etanercept, and trastuzumab. Samsung Bioepis’s biosimilars increase global patient access to life-changing biologic therapies while reducing healthcare costs.
How to Contact Samsung Bioepis Co., Ltd.
Phone
1-908-809-6300Medical Disclaimer
NowPatient has taken all reasonable steps to ensure that all material is factually accurate, complete, and current. However, the knowledge and experience of a qualified healthcare professional should always be sought after instead of using the information on this page. Before taking any drug, you should always speak to your doctor or another qualified healthcare provider.
The information provided here about medications is subject to change and is not meant to include all uses, precautions, warnings, directions, drug interactions, allergic reactions, or negative effects. The absence of warnings or other information for a particular medication does not imply that the medication or medication combination is appropriate for all patients or for all possible purposes.
Experienced a Side Effect?
Report to Yellow Card (UK) or MedWatch (US)
